Henry Schein earnings were $391.0M for the trailing 12 months ending Sep 27, 2025, with 29.7% growth year over year. The latest HSIC earnings report on Sep 27, 2025 announced Q3 2025 earnings of $101.0M, up 17.4% from last quarter. For the last reported fiscal year 2024 ending Dec 28, 2024, HSIC reported annual earnings of $390.0M, with -6.3% growth.
HSIC past earnings growth
How has HSIC's earnings growth performed historically?
On HSIC's earnings call on Invalid Date, Henry Schein (NASDAQ: HSIC) reported Q3 2025 earnings per share (EPS) of $0.84, up 6.33% year over year. Total HSIC earnings for the quarter were $101.00 million. In the same quarter last year, Henry Schein's earnings per share (EPS) was $0.79.
As of the last Henry Schein earnings report, Henry Schein is currently profitable. Henry Schein's net profit (also called net income) for the twelve months ending Sep 27, 2025 was $391.00 million, a 24.52% increase year over year.
What was HSIC's earnings growth in the past year?
As of Henry Schein's earnings date in Invalid Date, Henry Schein's earnings has grown 29.67% year over year. This is 8.27 percentage points lower than the US Medical Distribution industry earnings growth rate of 37.95%. HSIC earnings in the past year totalled $391.00 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.